CRF Inc. Strengthens Clinical Advisory Board
CRF Inc. (CRF), a global provider of electronic Patient Reported Outcomes (ePRO) and wireless data collection solutions for the Life Science industry, announces the expansion of its Clinical Advisory Board.
CRF INC. STRENGTHENS CLINICAL ADVISORY BOARD
- Internationally recognized experts provide experience and in-depth knowledge in clinical research and clinical trials management -
Waltham, MA – September 30, 2008: CRF Inc. (CRF), a leading global provider of electronic Patient Reported Outcomes (ePRO) and wireless data collection solutions for the Life Science industry, today announced the expansion of its expert Clinical Advisory Board. To offer clients strategic regulatory and quality services in clinical research, CRF strengthens its Clinical Advisory Board with the addition of Halloran Consulting Group Inc. (Halloran) experts.
These Halloran experts join Ms. Rachael King, board chairperson, and other members of CRF’s Clinical Advisory Board:
· Laurie Halloran, President and CEO, has over 20 years experience in the strategic development and management of clinical trials operations. She applies wisdom from her experience with baby biotech, big pharma, CROs and academia to help companies achieve capital efficient drug development.
· Greg Dombal, VP of Clinical and Regulatory Affairs, is an expert in regulatory strategy and submissions, from initial consult with regulatory agencies through to IND and ultimately NDA stage. He consults with companies to help create product development plans built for clinical efficiency and regulatory success.
· Shaghig Palanjian, VP of Consulting Services, has over 25 years experience in organizational management, quality systems and health informatics. Her expertise in clinical technology platforms helps companies adopt and implement the appropriate technologies to maximize the efficiency of information collection in clinical trials.
“Our Clinical Advisory Board was designed to quickly respond to the evolving requirements of our customers by drawing on the expertise of all its members,” said Rachael King, CRF Vice President of European and Asian Operations. “We are pleased to strengthen our Clinical Advisory Board with the addition of such internationally recognized Halloran clinical research experts. They will greatly help ensure that our efforts are aligned with providing specialist scientific and therapeutic advice for customers’ clinical programs.”
About CRF Inc.
CRF Inc. (CRF) is a leading global provider of electronic Patient Reported Outcomes (ePRO) and wireless data collection solutions for the Life Science Industry. Through innovative technology and a thorough understanding of drug development and mobile computing, the company is driving the change to safer and more efficient, paper-free clinical trials. CRF's technology has been used by more than 180,000 patients across 59 countries in 60 languages for 45 indications. The company has demonstrated one of the industry's highest patient compliance rates - an average 95% compliance through Phase I, II, III and IV clinical trials.
CRF's award-winning product, the TrialMax® suite, is a flexible and configurable ePRO technology that provides real-time patient monitoring, outstanding data accuracy and increased safety through compliance. The TrialMax® application’s unique features enable clinical trial sponsors to rapidly collect valuable data and conduct complex clinical trials with greater flexibility than other ePRO solutions. CRF's experience, combined with its dedication to achieving high quality and responsive customer service, has made the company one of the life science industry's most trusted partners. For more information, please visit www.crfhealth.com
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
